Results and rational behind breakthrough therapy-designated E-selectin antagonist for AML
5 years ago
[{"url":"https://i.ytimg.com/vi/YUHu-OlKj6k/hq720.jpg?sqp=-oaymwEcCOgCEMoBSFXyq4qpAw4IARUAAIhCGAFwAcABBg==&rs=AOn4CLAHkMqSg-iNWOYhy5wctUKav0jXLg","width":360,"height":202},{"url":"https://i.ytimg.com/vi/YUHu-OlKj6k/hq720.jpg?sqp=-oaymwEcCNAFEJQDSFXyq4qpAw4IARUAAIhCGAFwAcABBg==&rs=AOn4CLAisiM7zNNHkCjtwqcg4R3fAQeHtA","width":720,"height":404}]
[{"text":"The binding of E-selectin to leukemic cells has been shown to promote cell survival and chemotherapy resistance in acute\u00a0..."}]
{"name":"VJHemOnc \u2013 Video Journal of Hematological Oncology","id":"UCsQXL4_zTA-FoG9RA1tEGiw","thumbnails":[{"url":"https://yt3.ggpht.com/tLfkaYbACnFuAto-jU_XMyorvysy280aW3Kj1oDAKOH7nd58XYlz5rEL24x9ScNjruMr2YYw9w=s68-c-k-c0x00ffffff-no-rj","width":68,"height":68}],"link":"https://www.youtube.com/channel/UCsQXL4_zTA-FoG9RA1tEGiw"}
{"title":"Results and rational behind breakthrough therapy-designated E-selectin antagonist for AML by VJHemOnc \u2013 Video Journal of Hematological Oncology 107 views 5 years ago 1 minute, 11 seconds","duration":"1 minute, 11 seconds"}